Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

Market Cap	5.23B -17.7%
Revenue (ttm)	3.18B -20.1%
Net Income	326.30M -23.8%
EPS	2.16 -22.7%
Shares Out	153.40M
PE Ratio	15.80
Forward PE	n/a
Dividend	0.90 (2.66%)
Ex-Dividend Date	Apr 30, 2025

Volume	428,000
Average Volume	1,579,827
Open	33.88
Previous Close	34.07
Day's Range	33.86 - 34.20
52-Week Range	33.51 - 48.14
Beta	0.44
RSI	40.36
Earnings Date	Mar 21, 2026

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It provides medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company provides OTC, medical, and general health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 2,345
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600976

Financial Performance

In 2024, SHA:600976's revenue was 3.50 billion, a decrease of -16.81% compared to the previous year's 4.21 billion. Earnings were 362.18 million, a decrease of -30.54%.